JR Rettberg, J Yao, RD Brinton - Frontiers in neuroendocrinology, 2014 - Elsevier
Estrogen is a fundamental regulator of the metabolic system of the female brain and body. Within the brain, estrogen regulates glucose transport, aerobic glycolysis, and mitochondrial …
DW Fisher, DA Bennett, H Dong - Neurobiology of aging, 2018 - Elsevier
Clinical studies indicate that Alzheimer's disease (AD) disproportionately affects women in both disease prevalence and rate of symptom progression, but the mechanisms underlying …
RJ Santen, DC Allred, SP Ardoin… - The Journal of …, 2010 - academic.oup.com
Objective: Our objective was to provide a scholarly review of the published literature on menopausal hormonal therapy (MHT), make scientifically valid assessments of the available …
ZB Mills, RLM Faull, A Kwakowsky - International Journal of Molecular …, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for more than half of all dementia cases in the elderly. Interestingly, the clinical manifestations of …
M Boustani, B Peterson, L Hanson… - Annals of internal …, 2003 - acpjournals.org
Background: Dementia is a large and growing problem but is often not diagnosed in its earlier stages. Screening and earlier treatment could reduce the burden of suffering of this …
Sex differences in neurological disease extend from incidence, severity, progression and symptoms and may ultimately influence treatment. Cognitive disturbances are frequent in …
NL Sicotte, SM Liva, R Klutch, P Pfeiffer… - Annals of Neurology …, 2002 - Wiley Online Library
Multiple sclerosis patients who become pregnant experience a significant decrease in relapses that may be mediated by a shift in immune responses from T helper 1 to T helper 2 …
SA Castellon, PA Ganz, JE Bower… - Journal of clinical and …, 2004 - Taylor & Francis
The primary aim of the current study was to examine whether neurocognitive functioning among breast cancer survivors (BCS) exposed to systemic adjuvant chemotherapy differs …
DA Butterfield, CB Pocernich - CNS drugs, 2003 - Springer
Alzheimer's disease affects nearly 5 million Americans currently and, as a result of the baby boomer cohort, is predicted to affect 14 million Americans and 22 million persons totally …